Jiangsu Kanion Pharmaceutical Co.,Ltd.’s Net Profit Rose 30.8% in First Half of 2022

Jiangsu Kanion Pharmaceutical Co.,Ltd. (江苏康缘药业股份有限公司) (600557.SH) reported a net profit of 211.4 million yuan in the first half of 2022, up 30.8% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 18.5% year-on-year.

At the end of the reporting period, it had 6 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 22%.